Cyclacel Pharmaceuticals
CYCC
CYCC
29 hedge funds and large institutions have $19.5M invested in Cyclacel Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 5 closing their positions.
Holders
29
Holders Change
–
Holders Change %
0%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
9
Closed
5
Calls
$206K
Puts
$157K
Net Calls
+$49K
Net Calls Change
+$44K
Top Buyers
| 1 |
TLP
1
Tri Locum Partners
New York
|
$2.76M |
| 2 |
SCM
2
Silverarc Capital Management
Boston,
Massachusetts
|
$2.05M |
| 3 |
3
Two Sigma Advisers
New York
|
$640K |
| 4 |
VF
4
Virtu Financial
New York
|
$106K |
| 5 |
AAA
5
Affinity Asset Advisors
New York
|
$2.11M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $10.5K | 2,000 | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $7K | 1,340 | +1,340 | New |
|
28
Wells Fargo
San Francisco,
California
| $3K | 553 | -2 | -0.4% |
|
|
RE
29
RBC Europe
London,
United Kingdom
| $37 | 7 | – | – |
|
|
JGC
30
J. Goldman & Co
New York
| – | – | -442,315 | Closed |
|
|
BFM
31
Boothbay Fund Management
New York
| – | – | -10,545 | Closed |
|
32
Acadian Asset Management
Boston,
Massachusetts
| – | – | -6,502 | Closed |
|
|
TRCT
33
Tower Research Capital (TRC)
New York
| – | – | -233 | Closed |
|
34
UBS Group
Zurich,
Switzerland
| – | – | -72 | Closed |
|
35
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
36
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
37
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
38
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|